CLINICAL_TRIALS
trial_result
· 2016-03-17
Clinical Trial Update: Lenalidomide Plus Chemotherapy for AML [Phase 1]
Summary
A Phase 1 trial evaluating lenalidomide in combination with chemotherapy for acute myeloid leukemia has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Acute Myelogenous Leukemia | Phase 1 | Status: COMPLETED